Literature DB >> 33671286

Molecular Dissection of Escherichia coli CpdB: Roles of the N Domain in Catalysis and Phosphate Inhibition, and of the C Domain in Substrate Specificity and Adenosine Inhibition.

Iralis López-Villamizar1, Alicia Cabezas1, Rosa María Pinto1, José Canales1, João Meireles Ribeiro1, Joaquim Rui Rodrigues2, María Jesús Costas1, José Carlos Cameselle1.   

Abstract

CpdB is a 3'-nucleotidase/2'3'-cyclic nucleotide phosphodiesterase, active also with reasonable efficiency on cyclic dinucleotides like c-di-AMP (3',5'-cyclic diadenosine monophosphate) and c-di-GMP (3',5'-cyclic diadenosine monophosphate). These are regulators of bacterial physiology, but are also pathogen-associated molecular patterns recognized by STING to induce IFN-β response in infected hosts. The cpdB gene of Gram-negative and its homologs of gram-positive bacteria are virulence factors. Their protein products are extracytoplasmic enzymes (either periplasmic or cell-wall anchored) and can hydrolyze extracellular cyclic dinucleotides, thus reducing the innate immune responses of infected hosts. This makes CpdB(-like) enzymes potential targets for novel therapeutic strategies in infectious diseases, bringing about the necessity to gain insight into the molecular bases of their catalytic behavior. We have dissected the two-domain structure of Escherichia coli CpdB to study the role of its N-terminal and C-terminal domains (CpdB_Ndom and CpdB_Cdom). The specificity, kinetics and inhibitor sensitivity of point mutants of CpdB, and truncated proteins CpdB_Ndom and CpdB_Cdom were investigated. CpdB_Ndom contains the catalytic site, is inhibited by phosphate but not by adenosine, while CpdB_Cdom is inactive but contains a substrate-binding site that determines substrate specificity and adenosine inhibition of CpdB. Among CpdB substrates, 3'-AMP, cyclic dinucleotides and linear dinucleotides are strongly dependent on the CpdB_Cdom binding site for activity, as the isolated CpdB_Ndom showed much-diminished activity on them. In contrast, 2',3'-cyclic mononucleotides and bis-4-nitrophenylphosphate were actively hydrolyzed by CpdB_Ndom, indicating that they are rather independent of the CpdB_Cdom binding site.

Entities:  

Keywords:  catalytic site; cyclic dinucleotide; extracytoplasmic phosphodiesterase; inhibitor sensitivity; pathogen–host interaction; point mutant; protein domain; substrate specificity; substrate-binding site; truncated protein

Mesh:

Substances:

Year:  2021        PMID: 33671286      PMCID: PMC7922932          DOI: 10.3390/ijms22041977

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  59 in total

1.  Physiology and pathogenicity of cpdB deleted mutant of avian pathogenic Escherichia coli.

Authors:  Huifang Liu; Liping Chen; Wei Si; Chunlai Wang; Fangna Zhu; Guangxing Li; Siguo Liu
Journal:  Res Vet Sci       Date:  2016-11-17       Impact factor: 2.534

2.  The cyclic phosphodiesterases (3'-nucleotidases) of the enterobacteriaceae.

Authors:  H C Neu
Journal:  Biochemistry       Date:  1968-10       Impact factor: 3.162

3.  The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.

Authors:  H C Neu; L A Heppel
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

4.  The 5'-nucleotidases and cyclic phosphodiesterases (3'-nucleotidases) of the Enterobacteriaceae.

Authors:  H C Neu
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

5.  X-ray structure of the Escherichia coli periplasmic 5'-nucleotidase containing a dimetal catalytic site.

Authors:  T Knöfel; N Sträter
Journal:  Nat Struct Biol       Date:  1999-05

6.  Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.

Authors:  Lijun Sun; Jiaxi Wu; Fenghe Du; Xiang Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

7.  Contribution of the two domains of E. coli 5'-nucleotidase to substrate specificity and catalysis.

Authors:  Ulrike Krug; Rica Patzschke; Matthias Zebisch; Jochen Balbach; Norbert Sträter
Journal:  FEBS Lett       Date:  2013-01-17       Impact factor: 4.124

8.  CDP-alcohol hydrolase, a very efficient activity of the 5'-nucleotidase/UDP-sugar hydrolase encoded by the ushA gene of Yersinia intermedia and Escherichia coli.

Authors:  Isabel Alves-Pereira; José Canales; Alicia Cabezas; Paloma Martín Cordero; María Jesús Costas; José Carlos Cameselle
Journal:  J Bacteriol       Date:  2008-07-18       Impact factor: 3.490

9.  Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation.

Authors:  J M Word; S C Lovell; J S Richardson; D C Richardson
Journal:  J Mol Biol       Date:  1999-01-29       Impact factor: 5.469

Review 10.  Conserved strategies for pathogen evasion of cGAS-STING immunity.

Authors:  James B Eaglesham; Philip J Kranzusch
Journal:  Curr Opin Immunol       Date:  2020-04-15       Impact factor: 7.486

View more
  3 in total

1.  Substrate Specificity of Chimeric Enzymes Formed by Interchange of the Catalytic and Specificity Domains of the 5'-Nucleotidase UshA and the 3'-Nucleotidase CpdB.

Authors:  Alicia Cabezas; Iralis López-Villamizar; María Jesús Costas; José Carlos Cameselle; João Meireles Ribeiro
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

2.  Enzyme Characterization of Pro-virulent SntA, a Cell Wall-Anchored Protein of Streptococcus suis, With Phosphodiesterase Activity on cyclic-di-AMP at a Level Suited to Limit the Innate Immune System.

Authors:  Alicia Cabezas; María Jesús Costas; José Canales; Rosa María Pinto; Joaquim Rui Rodrigues; João Meireles Ribeiro; José Carlos Cameselle
Journal:  Front Microbiol       Date:  2022-03-22       Impact factor: 5.640

3.  Improvement on Thermostability of Pectate Lyase and Its Potential Application to Ramie Degumming.

Authors:  Huan Xu; Xiangyuan Feng; Qi Yang; Ke Zheng; Le Yi; Shengwen Duan; Lifeng Cheng
Journal:  Polymers (Basel)       Date:  2022-07-15       Impact factor: 4.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.